With oil and gas prices rising and the sale of its assets in the Permian basin wrapped-up, investors are expecting shareholder returns to accelerate in 2022.
M&S raises expectations as its food halls flourish, the bidding war for Morrisons takes another turn, AstraZeneca’s new potential coronavirus drug proves effective, and OSB grows cautiously confident as the economy recovers.